An atomic resolution model for assembly, architecture, and function of the Dr adhesins.

Pathogenic bacteria possess adhesion protein complexes that play essential roles in targeting host cells and in propagating infection. Although each family of adhesion proteins is generally associated with a specific human disease, the Dr family from Escherichia coli is a notable exception, as its members are associated with both diarrheal and urinary tract infections. These proteins are reported to form both fimbrial and afimbrial structures at the bacterial cell surface and target a common host cell receptor, the decay-accelerating factor (DAF or CD55). Using the newly solved three-dimensional structure of AfaE, we have constructed a robust atomic resolution model that reveals the structural basis for assembly by donor strand complementation and for the architecture of capped surface fibers.

[1]  J. Atkinson,et al.  Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[2]  P. Gounon,et al.  Recognition of the cellular β1‐chain integrin by the bacterial AfaD invasin is implicated in the internalization of afa‐expressing pathogenic Escherichia coli strains , 2003, Cellular microbiology.

[3]  P Lukacik,et al.  Complement regulation at the molecular level: the structure of decay-accelerating factor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[4]  S. Falkow,et al.  Distribution and degree of heterogeneity of the afimbrial-adhesin-encoding operon (afa) among uropathogenic Escherichia coli isolates , 1988, Infection and immunity.

[5]  L. Trabulsi,et al.  Afa, a Diffuse Adherence Fibrillar Adhesin Associated with Enteropathogenic Escherichia coli , 2002, Infection and Immunity.

[6]  G. Schoolnik,et al.  Cloning and expression of an afimbrial adhesin (AFA-I) responsible for P blood group-independent, mannose-resistant hemagglutination from a pyelonephritic Escherichia coli strain , 1984, Infection and immunity.

[7]  G. Smith,et al.  Biological activity, membrane‐targeting modification, and crystallization of soluble human decay accelerating factor expressed in E. coli , 2004, Protein science : a publication of the Protein Society.

[8]  S. Hultgren,et al.  Bacterial pili: molecular mechanisms of pathogenesis. , 2000, Current opinion in microbiology.

[9]  S. Moseley,et al.  Mutational analysis of receptor binding mediated by the Dr family of Escherichia coli adhesins , 1997, Molecular microbiology.

[10]  T. Whittam,et al.  Characterization of AfaE Adhesins Produced by Extraintestinal and Intestinal Human Escherichia coliIsolates: PCR Assays for Detection of Afa Adhesins That Do or Do Not Recognize Dr Blood Group Antigens , 2001, Journal of Clinical Microbiology.

[11]  Scott J. Hultgren,et al.  Bacterial Adhesins: Common Themes and Variations in Architecture and Assembly , 1999, Journal of bacteriology.

[12]  Mathura S Venkatarajan,et al.  Structure-Function Analysis of Decay-Accelerating Factor: Identification of Residues Important for Binding of the Escherichia coli Dr Adhesin and Complement Regulation , 2002, Infection and Immunity.

[13]  S. Moseley,et al.  Molecular characterization of a fimbrial adhesin, F1845, mediating diffuse adherence of diarrhea-associated Escherichia coli to HEp-2 cells , 1989, Journal of bacteriology.

[14]  G. Ball,et al.  Solution structure of a functionally active fragment of decay-accelerating factor , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[15]  O. Spiller,et al.  Mapping CD55 Function , 2003, The Journal of Biological Chemistry.

[16]  Michael Nilges,et al.  ARIA: automated NOE assignment and NMR structure calculation , 2003, Bioinform..

[17]  G. Waksman,et al.  Chaperone Priming of Pilus Subunits Facilitates a Topological Transition that Drives Fiber Formation , 2002, Cell.

[18]  P. Gounon,et al.  Immunocytochemistry of the AfaE adhesin and AfaD invasin produced by pathogenic Escherichia coli strains during interaction of the bacteria with HeLa cells by high-resolution scanning electron microscopy. , 2000, Microbes and infection.

[19]  T. Pawson,et al.  Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation. , 1994, Biochemistry.

[20]  V. Nussenzweig,et al.  Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes , 1984, The Journal of experimental medicine.

[21]  V. Stojanoff,et al.  X-ray structure of the FimC-FimH chaperone-adhesin complex from uropathogenic Escherichia coli. , 1999, Science.

[22]  V. Nussenzweig,et al.  Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins , 1987, Nature.

[23]  J M Thornton,et al.  LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. , 1995, Protein engineering.

[24]  V. Nussenzweig,et al.  Amelioration of lytic abnormalities of paroxysmal nocturnal hemoglobinuria with decay-accelerating factor. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. Selvarangan,et al.  Role of Decay-Accelerating Factor Domains and Anchorage in Internalization of Dr-Fimbriated Escherichia coli , 2000, Infection and Immunity.

[26]  R. Selvarangan,et al.  Family of Escherichia coli Dr adhesins: decay-accelerating factor receptor recognition and invasiveness. , 2001, The Journal of infectious diseases.

[27]  G. Waksman,et al.  PapD-like chaperones provide the missing information for folding of pilin proteins. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[28]  A. Labigne,et al.  Characterization of plasmid-borne afa-3 gene clusters encoding afimbrial adhesins expressed by Escherichia coli strains associated with intestinal or urinary tract infections , 1993, Infection and immunity.

[29]  G. Waksman,et al.  Structural basis of chaperone function and pilus biogenesis. , 1999, Science.

[30]  S. Moseley,et al.  Molecular structure of the Dr adhesin: nucleotide sequence and mapping of receptor-binding domain by use of fusion constructs , 1991, Infection and immunity.

[31]  J. Risteli,et al.  The O75X adhesin of uropathogenic Escherichia coli is a type IV collagen‐binding protein , 1989, Molecular microbiology.

[32]  Christian Griesinger,et al.  Heteronuclear multidimensional NMR experiments for the structure determination of proteins in solution employing pulsed field gradients , 1999 .

[33]  B. Nowicki,et al.  dra-related X adhesins of gestational pyelonephritis-associated Escherichia coli recognize SCR-3 and SCR-4 domains of recombinant decay-accelerating factor , 1995, Infection and immunity.

[34]  J. Almond,et al.  Interaction between echovirus 7 and its receptor, decay-accelerating factor (CD55): evidence for a secondary cellular factor in A-particle formation , 1997 .

[35]  B. Nowicki,et al.  Molecular analysis and epidemiology of the Dr hemagglutinin of uropathogenic Escherichia coli , 1989, Infection and immunity.

[36]  A. Labigne,et al.  The afimbrial adhesive sheath encoded by the afa‐3 gene cluster of pathogenic Escherichia coli is composed of two adhesins , 1996, Molecular microbiology.

[37]  Stefan D Knight,et al.  Structure and Biogenesis of the Capsular F1 Antigen from Yersinia pestis Preserved Folding Energy Drives Fiber Formation , 2003, Cell.

[38]  R. Samudrala,et al.  Identification of amino acids in the Dr adhesin required for binding to decay‐accelerating factor , 2002, Molecular microbiology.

[39]  C. Mold,et al.  Localization of classical and alternative pathway regulatory activity within the decay-accelerating factor. , 1996, Journal of immunology.

[40]  B. Nowicki,et al.  A hemagglutinin of uropathogenic Escherichia coli recognizes the Dr blood group antigen , 1988, Infection and immunity.

[41]  G Waksman,et al.  Chaperone-assisted pilus assembly and bacterial attachment. , 2000, Current opinion in structural biology.